OSTCP5

Across TCGA pan-cancer cohorts, OSTCP5 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated OSTCP5 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OSTCP5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OSTCP5 expression acts as an unfavorable survival marker, although some lineages such as LUSC and LAML show a favorable association.

BLCA, LUSC, and BRCA are the cancer types where OSTCP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.246	0.474	<.001	120	view →
LUSC	DFS	Tertile	All	0.780	0.585	<.001	57	view →
BRCA	OS	Tertile	All	0.887	0.933	.010	24	view →
STAD	DFS	Quartile	II,III,IV	0.503	0.773	.013	24	view →
SARC	OS	Tertile	All	0.510	0.770	<.001	24	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
LAML	DFS	Median	All	0.559	0.269	.006	18	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	18	view →
LIHC	OS	Tertile	All	0.536	0.729	.007	15	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	15	view →
GBM	DFS	Median	All	0.210	0.297	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

OSTCP5–BLCA (DFS)

Open the BLCA breakdown →